The Emergence of Sacral Nerve Stimulation as a Treatment for Pelvic Floor Disorders

What is Sacral Nerve Stimulation?

Sacral nerve stimulation (SNS) is a minimally invasive treatment used for certain pelvic floor disorders including overactive bladder, fecal incontinence, and chronic pelvic pain. During SNS, a thin lead is placed near sacral nerves in the lower back that control bladder and bowel function. Low-voltage electricity is delivered through the lead to modulate nerve signaling and relieve symptoms.

History and Mechanism of Action

The use of SNS originated in the 1980s as a treatment for urge incontinence. Early studies found that electrical stimulation of sacral nerve roots S3 and S4 could help treat overactive bladder. It was later approved by the FDA for urinary incontinence and fecal incontinence. The exact mechanism is still under investigation, but SNS is believed to regulate activity in the pelvic floor muscles, bladder, and bowel through modulation of signaling in the autonomic nervous system. By altering nerve impulses, it can help restore normal bladder and bowel control and sensation.

Sacral Nerve Stimulation as a Treatment for Overactive Bladder

Overactive bladder syndrome affects up to 16% of adults and causes frequent urination with sudden urgency that is difficult to delay. Lifestyle changes and behavioral therapy are often first-line treatments, but medication can have side effects and lose effectiveness over time. Numerous clinical trials have found SNS to significantly relieve overactive bladder symptoms and reduce incontinence episodes in up to 85% of patients when medication fails. It provides an alternative to more invasive surgical treatments like bladder neuromodulation. SNS is minimally invasive, allows patients to avoid lifetime drug use, and has been shown to maintain effects for at least 10 years.

Applications for Fecal Incontinence

Fecal incontinence, or the inability to control bowel movements, affects up to 15% of older adults in nursing homes. It greatly impairs quality of life. Lifestyle and dietary modifications provide limited relief, and surgery is not always suitable. Randomized controlled studies showed SNS reduced incontinence episodes by up to 50-80% in patients with mild to moderate fecal incontinence when conservative options failed. It provides an important treatment option before considering potentially risky surgical interventions like placement of an artificial bowel sphincter. With high patient satisfaction, SNS represents a safe and effective minimally invasive therapy.

Treating Chronic Pelvic Pain

Chronic pelvic pain is a chronic condition often associated with disorders like endometriosis, interstitial cystitis, and pelvic floor dysfunction. Up to 15% of women suffer from debilitating chronic pelvic pain. Besides conservative treatments, Global Sacral Nerve Stimulation has shown promise based on small pilot studies. Electrical impulses may help relax contracted pelvic floor muscles, improve blood flow, modulate pain pathways, and restore normal sensations in the pelvis. Though research is preliminary, some patients report significant long-term relief of pelvic pain symptoms with SNS. Larger controlled trials are still needed, but SNS presents a novel approach for this difficult to treat condition.

Global Diffusion and Acceptance of SNS

Since its approval for fecal incontinence in 2011, use of SNS has expanded globally. European centers have the most clinical experience with over 10,000 implantations performed. SNS is now routinely used across major hospitals in the UK, France, Germany, Italy and Spain for conditions like overactive bladder and fecal incontinence when conservative options fail. Regulatory approval has allowed Medicare coverage in the U.S. and private insurers also provide coverage. The Asia Pacific region including Japan, Australia, India and China are also seeing a rise in SNS utilization in major medical centers as an established third-line treatment. With growing recognition of its clinical benefits and safety profile compared to other surgical interventions, SNS has emerged as a valuable global treatment option for debilitating pelvic floor disorders.

Ongoing Advancement of Sacral Nerve Stimulation Devices and Techniques

Major medical device companies continue driving innovation to enhance SNS therapy outcomes and patient experience. New rechargeable implantable pulse generators with longer battery life up to 10 years have been introduced. Minimally invasive techniques now allow for complete insertion of percutaneous leads and devices under local anesthesia. Wireless and programmable SNS systems enable remote adjustments by physicians. Recent studies also explore use of high-frequency 10 kHz stimulation and multi-contact leads that may provide more targeted therapy for different conditions. With ongoing research, future SNS technology could enable personalized stimulation programs tailored to individual patient anatomy and symptoms. As implantation procedures become less invasive and technology more sophisticated, SNS availability and global adoption will likely continue expanding in the coming years.

Get more insights on Global Sacral Nerve Stimulation

About Author:

Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. (https://www.linkedin.com/in/ravina-pandya-1a3984191)